The document provides information on bio-medical waste management rules in India. It discusses that bio-medical waste is waste generated from healthcare facilities and includes human tissues, blood, chemicals, sharps etc. The rules classify waste into different color coded categories and prescribe standards for segregation, collection, storage, transport and treatment of waste. It highlights that improper management of bio-medical waste poses health and safety risks. The rules have been amended over time to better regulate waste management. Strict adherence to the waste management procedures outlined in the rules is important to ensure safety of health workers and the public.
This document discusses biomedical waste and its management. It defines biomedical waste as anything used or tested on individuals or from biological experiments. It is generated from healthcare, research, and laboratory facilities. Most waste is non-infectious but some is infectious or hazardous. The waste is classified into 10 categories and different treatment methods are outlined depending on the category, such as incineration, autoclaving, or chemical treatment. Proper management is important to minimize infectious waste and treat it safely according to environmental legislation.
Biomedical waste includes solid waste generated during medical procedures and contains infectious and hazardous materials. It is important to properly manage biomedical waste to prevent the spread of diseases and environmental pollution. There are several categories of biomedical waste that require specific handling and disposal methods according to color-coded containers and bags. Improper management of biomedical waste can lead to infections in patients and waste handlers. Key steps to manage biomedical waste include segregation, transportation to treatment facilities, and using techniques like incineration, autoclaving, and chemical treatment to dispose of waste safely.
The document discusses bio-medical waste management. It begins by introducing the types of hazardous materials generated in hospitals, including infected materials, cytotoxic drugs, and radioactive substances. It then describes the nature and quantities of hospital waste, classifying it as hazardous (15%) and non-hazardous (85%). Hazardous waste is further divided into infectious (10%) and toxic (5%) categories. The document outlines the health hazards of improper management, principles of infection control, and the Bio-Medical Waste Rules for treatment and disposal of different categories of waste.
The document discusses biomedical waste (BMW) management. It defines BMW and notes that it is generated from hospitals, clinics, labs, and other medical facilities. BMW is categorized based on infectivity and other hazardous properties. The key aspects of an effective BMW management program are waste segregation, collection, storage, transportation, and treatment. Occupational safety and regulatory compliance are also important. The document provides details on BMW rules and guidelines in India to help facilities properly manage this waste to protect human health and the environment.
The document provides an overview of biomedical waste (BMW) in India, including its definition, categories, generation and management issues. Some key points:
- BMW includes waste generated from healthcare facilities and includes sharps, infectious, pathological and pharmaceutical waste.
- India generates over 3 million tonnes of BMW annually from over 95,000 healthcare facilities. Treatment and disposal of BMW is inadequate, posing risks to health and environment.
- The Biomedical Waste Rules of 1998 govern BMW management and require segregation, storage, transportation, treatment and disposal of different BMW categories. However, compliance remains a challenge.
The document discusses biomedical waste management. It defines biomedical waste and lists various sources that produce such waste, such as hospitals, clinics, laboratories, etc. It categorizes waste based on potential hazards such as infectiousness, toxicity, radioactivity. The key aspects of biomedical waste management are segregation, collection, storage, transportation, and treatment. Treatment methods include incineration, chemical disinfection, autoclaving. The Biomedical Waste Management Rules issued by the Ministry of Environment and Forests govern biomedical waste handling and disposal in India.
This document discusses biomedical waste management. It begins with an introduction about the importance of proper hospital waste management for patient and staff health. It then defines key terminology related to biomedical waste. It classifies healthcare waste into categories including biomedical waste, general waste, and other wastes. It describes the color coding and container types used for waste segregation. It provides guidelines for biomedical waste collection, packaging, labeling, and interim storage. It concludes with information on biomedical waste treatment and disposal facilities and specific COVID-19 waste handling guidelines.
This document discusses biomedical waste and its management. It defines biomedical waste as anything used or tested on individuals or from biological experiments. It is generated from healthcare, research, and laboratory facilities. Most waste is non-infectious but some is infectious or hazardous. The waste is classified into 10 categories and different treatment methods are outlined depending on the category, such as incineration, autoclaving, or chemical treatment. Proper management is important to minimize infectious waste and treat it safely according to environmental legislation.
Biomedical waste includes solid waste generated during medical procedures and contains infectious and hazardous materials. It is important to properly manage biomedical waste to prevent the spread of diseases and environmental pollution. There are several categories of biomedical waste that require specific handling and disposal methods according to color-coded containers and bags. Improper management of biomedical waste can lead to infections in patients and waste handlers. Key steps to manage biomedical waste include segregation, transportation to treatment facilities, and using techniques like incineration, autoclaving, and chemical treatment to dispose of waste safely.
The document discusses bio-medical waste management. It begins by introducing the types of hazardous materials generated in hospitals, including infected materials, cytotoxic drugs, and radioactive substances. It then describes the nature and quantities of hospital waste, classifying it as hazardous (15%) and non-hazardous (85%). Hazardous waste is further divided into infectious (10%) and toxic (5%) categories. The document outlines the health hazards of improper management, principles of infection control, and the Bio-Medical Waste Rules for treatment and disposal of different categories of waste.
The document discusses biomedical waste (BMW) management. It defines BMW and notes that it is generated from hospitals, clinics, labs, and other medical facilities. BMW is categorized based on infectivity and other hazardous properties. The key aspects of an effective BMW management program are waste segregation, collection, storage, transportation, and treatment. Occupational safety and regulatory compliance are also important. The document provides details on BMW rules and guidelines in India to help facilities properly manage this waste to protect human health and the environment.
The document provides an overview of biomedical waste (BMW) in India, including its definition, categories, generation and management issues. Some key points:
- BMW includes waste generated from healthcare facilities and includes sharps, infectious, pathological and pharmaceutical waste.
- India generates over 3 million tonnes of BMW annually from over 95,000 healthcare facilities. Treatment and disposal of BMW is inadequate, posing risks to health and environment.
- The Biomedical Waste Rules of 1998 govern BMW management and require segregation, storage, transportation, treatment and disposal of different BMW categories. However, compliance remains a challenge.
The document discusses biomedical waste management. It defines biomedical waste and lists various sources that produce such waste, such as hospitals, clinics, laboratories, etc. It categorizes waste based on potential hazards such as infectiousness, toxicity, radioactivity. The key aspects of biomedical waste management are segregation, collection, storage, transportation, and treatment. Treatment methods include incineration, chemical disinfection, autoclaving. The Biomedical Waste Management Rules issued by the Ministry of Environment and Forests govern biomedical waste handling and disposal in India.
This document discusses biomedical waste management. It begins with an introduction about the importance of proper hospital waste management for patient and staff health. It then defines key terminology related to biomedical waste. It classifies healthcare waste into categories including biomedical waste, general waste, and other wastes. It describes the color coding and container types used for waste segregation. It provides guidelines for biomedical waste collection, packaging, labeling, and interim storage. It concludes with information on biomedical waste treatment and disposal facilities and specific COVID-19 waste handling guidelines.
This document discusses biomedical waste management. It defines biomedical waste and classifies it into 10 categories. It describes the various treatment and disposal methods used like incineration, autoclaving, chemical treatment, and secured landfilling. It discusses the health hazards of improper waste handling and the regulations in place in India for biomedical waste management according to the Bio-Medical Waste Rules of 1998.
This document discusses bio-medical waste management. It defines bio-medical waste and lists typical waste compositions from healthcare facilities. It categorizes waste as infectious, pathological, pharmaceuticals, chemicals, sharps and radioactive. It discusses the objectives, practices and strategies for safe waste management including collection, segregation, transportation, storage, treatment and disposal methods like incineration, autoclaving, chemical disinfection and sanitary landfilling. The Bio-Medical Waste Management Rules 2016 in India are also summarized.
This document discusses the management of biomedical waste. It defines biomedical waste as waste generated during diagnosis, treatment, or immunization of humans or animals. It notes that 85% of healthcare waste is non-infectious, while 10-25% is hazardous. Hazardous waste is further divided into two types - infectious solid waste and hazardous chemicals. The document outlines the different categories of biomedical waste and appropriate treatment and disposal methods for each category.
The document discusses bio-medical waste management. It defines bio-medical waste and outlines the objectives of proper management which are to minimize waste production, recycle waste when possible, treat waste through safe methods, ensure safety during handling, and prevent healthcare-associated infections. It classifies waste into four categories (yellow, red, white, blue) and describes the appropriate treatment and disposal methods for each category of waste.
This document provides an overview of biomedical waste management rules and regulations in India. It defines biomedical waste and outlines the key steps for managing waste, including characterization, quantification, segregation, storage, transportation, treatment, and disposal. It discusses the current scenario of biomedical waste generation and treatment in India. It also summarizes the major differences between the 1998 and 2016 biomedical waste management rules, including changes to waste categories, treatment standards, and operator duties. Formats for authorization applications, annual reports, and accident reporting are also included.
Biomedical waste management in India is important to prevent disease transmission. The types of biomedical waste include infectious waste like human tissues and sharps, and non-infectious waste like packaging. Improper management can spread hepatitis, HIV, and other diseases. The Bio-Medical Waste Rules were created in 1998 to regulate segregation, storage, transportation, treatment and disposal of wastes. Case studies show that some hospitals failed to properly dispose of wastes, putting public health at risk. Strong enforcement of waste management practices is still needed.
1. The document discusses the issues and challenges of biomedical waste management in India. It defines biomedical waste and outlines its various categories.
2. Proper management of biomedical waste is important to minimize health risks and environmental pollution. It involves waste segregation, collection, transportation, treatment and disposal. Common treatment methods include incineration, autoclaving, and chemical disinfection.
3. While rules and regulations around biomedical waste management exist in India, challenges remain around implementation, resources, awareness, and coordination between different stakeholders. Proper management requires cooperation from all healthcare professionals and facilities.
The document summarizes the Biomedical Waste (Management and Handling) Rules, 1998 which provide rules for handling biomedical waste in India. It outlines 10 categories of biomedical waste and their treatment methods. It specifies procedures for segregation, packaging, transportation, and storage of waste. Authorized persons must treat waste within 48 hours and maintain records. The prescribed authority in each state or union territory will implement these rules by granting authorization to occupiers and ensuring compliance.
This document summarizes biomedical waste management. It defines biomedical waste and categories waste into 10 types. Improper management poses infection risks to patients, waste handlers, and the public. The key needs are segregation by color-coding, safe transportation, and treatment via incineration, autoclaving, or chemical disinfection. Indian law requires hospitals to follow the Biomedical Waste Rules of 1998 for safe handling from point of generation to final disposal. Proper management is a legal and social responsibility to prevent disease transmission and environmental pollution.
The document discusses strategies for hospital waste management. It defines biomedical waste and outlines the key elements of the BMW Act and Rules, including classifications of waste, standards, and management steps. BMW is segregated into 4 categories and treated through various processes like incineration, autoclaving, or hydroclaving before disposal. Proper handling and treatment is important to reduce health and environmental risks from hazardous waste.
This document discusses bio-medical waste management. It defines different types of bio-medical waste and categories them based on risk level. It explains the potential health hazards posed by different types of waste and regulations for their proper treatment and disposal. The key methods of waste treatment discussed are incineration, autoclaving, chemical disinfection, and secured landfilling.
India is likely to generate about 775.5 tons of medical wast per day by 2020, from the current level of 550.9 tons per day growing at CAGR about 7%.
Safe and effective management of waste is not only a legal necessity but also a social responsibility.
The document discusses bio-medical waste management. It defines bio-medical waste and its categories. It notes that approximately 40 tons of waste is generated daily in India, but only 30% undergoes proper disposal. It outlines the various treatment and disposal methods for different categories of waste, including incineration, autoclaving, chemical treatment, and secured landfilling. Color coding and container requirements are also specified. The risks of exposure to healthcare waste include infections, genotoxicity, chemical toxicity, and radioactivity hazards. Proper waste management requires adherence to government rules and public education.
The document discusses biomedical waste management. It defines biomedical waste as waste generated during diagnosis, treatment, or immunization of humans or animals. It notes that biomedical waste includes infectious waste, pathological waste, sharps waste, pharmaceutical waste, genotoxic waste, chemical waste, and radioactive waste. The document also outlines the Ministry of Environment and Forest's classification of biomedical waste into 10 categories and the recommended treatment and disposal methods for each category. Key sources of biomedical waste are identified as hospitals, clinics, labs, and other healthcare facilities.
This document discusses bio medical waste management. It defines different types of hospital waste including biomedical waste. It classifies waste into hazardous and non-hazardous categories. Hazardous waste is further divided into infectious and toxic types. Ten categories of biomedical waste are outlined along with their color coding and appropriate treatment methods. The key steps in waste management are identified as survey, segregation, storage, transportation, treatment, and disposal. Common health risks of improper waste handling are also noted.
-Bio-Medical Waste
-Contents:
-Evolution of Bio-Medical Waste in India
-Biomedical Waste
-Need of Rules for Bio-Medical Waste
-Present Scenario in India
-Disease Caused by Improper Disposal of Waste
-BMW(H&M) 1998
-Major Differences between BMW 1998 and BMW 2016
-BMW (H&M) 2016
-Conclusion
Evolution of Bio-Medical Waste Management Rules in India:
-First Bio-Medical Rules were notified by the Govt. of India, erstwhile
MOEF on 20th July 1998.
-Modification in the next following years (2000, 2003 and 2011)
-BMW rules 2011 remained as the draft
-MOEFCC in March 2016 has amended the BMWM rules.
-BMW Management 2016 was released on 27 March 2016
Bio-Medical Waste:
means any waste, which is generated during the diagnosis, treatment or immunisation of human beings or animals
or research activities pertaining thereto
or in the production or testing of biological or in health camps, including the categories mentioned in Schedule I appended to these rules;
The document outlines guidelines for managing biomedical waste in hospitals. It discusses categorizing waste based on infectivity, proper segregation, collection, storage, and disposal methods. Training of staff, safety precautions, and regulatory compliance are important aspects of the waste management process. The goal is to minimize infectious waste production, safely dispose of waste, and prevent the spread of hospital-acquired infections.
This document provides information on the Bio Medical Waste Management Rules, 2016 in India. It introduces the rules and their objective of providing regulatory framework for managing bio-medical waste. It defines bio-medical waste and explains the types of waste generated from healthcare facilities. It emphasizes the importance of proper waste segregation and describes the 4 waste categories and their treatment and disposal requirements according to the rules. Improper management can pose health and environmental risks. The rules aim to standardize waste management practices across India.
This document discusses biomedical waste management. It defines biomedical waste and classifies it into 10 categories. It describes the various treatment and disposal methods used like incineration, autoclaving, chemical treatment, and secured landfilling. It discusses the health hazards of improper waste handling and the regulations in place in India for biomedical waste management according to the Bio-Medical Waste Rules of 1998.
This document discusses bio-medical waste management. It defines bio-medical waste and lists typical waste compositions from healthcare facilities. It categorizes waste as infectious, pathological, pharmaceuticals, chemicals, sharps and radioactive. It discusses the objectives, practices and strategies for safe waste management including collection, segregation, transportation, storage, treatment and disposal methods like incineration, autoclaving, chemical disinfection and sanitary landfilling. The Bio-Medical Waste Management Rules 2016 in India are also summarized.
This document discusses the management of biomedical waste. It defines biomedical waste as waste generated during diagnosis, treatment, or immunization of humans or animals. It notes that 85% of healthcare waste is non-infectious, while 10-25% is hazardous. Hazardous waste is further divided into two types - infectious solid waste and hazardous chemicals. The document outlines the different categories of biomedical waste and appropriate treatment and disposal methods for each category.
The document discusses bio-medical waste management. It defines bio-medical waste and outlines the objectives of proper management which are to minimize waste production, recycle waste when possible, treat waste through safe methods, ensure safety during handling, and prevent healthcare-associated infections. It classifies waste into four categories (yellow, red, white, blue) and describes the appropriate treatment and disposal methods for each category of waste.
This document provides an overview of biomedical waste management rules and regulations in India. It defines biomedical waste and outlines the key steps for managing waste, including characterization, quantification, segregation, storage, transportation, treatment, and disposal. It discusses the current scenario of biomedical waste generation and treatment in India. It also summarizes the major differences between the 1998 and 2016 biomedical waste management rules, including changes to waste categories, treatment standards, and operator duties. Formats for authorization applications, annual reports, and accident reporting are also included.
Biomedical waste management in India is important to prevent disease transmission. The types of biomedical waste include infectious waste like human tissues and sharps, and non-infectious waste like packaging. Improper management can spread hepatitis, HIV, and other diseases. The Bio-Medical Waste Rules were created in 1998 to regulate segregation, storage, transportation, treatment and disposal of wastes. Case studies show that some hospitals failed to properly dispose of wastes, putting public health at risk. Strong enforcement of waste management practices is still needed.
1. The document discusses the issues and challenges of biomedical waste management in India. It defines biomedical waste and outlines its various categories.
2. Proper management of biomedical waste is important to minimize health risks and environmental pollution. It involves waste segregation, collection, transportation, treatment and disposal. Common treatment methods include incineration, autoclaving, and chemical disinfection.
3. While rules and regulations around biomedical waste management exist in India, challenges remain around implementation, resources, awareness, and coordination between different stakeholders. Proper management requires cooperation from all healthcare professionals and facilities.
The document summarizes the Biomedical Waste (Management and Handling) Rules, 1998 which provide rules for handling biomedical waste in India. It outlines 10 categories of biomedical waste and their treatment methods. It specifies procedures for segregation, packaging, transportation, and storage of waste. Authorized persons must treat waste within 48 hours and maintain records. The prescribed authority in each state or union territory will implement these rules by granting authorization to occupiers and ensuring compliance.
This document summarizes biomedical waste management. It defines biomedical waste and categories waste into 10 types. Improper management poses infection risks to patients, waste handlers, and the public. The key needs are segregation by color-coding, safe transportation, and treatment via incineration, autoclaving, or chemical disinfection. Indian law requires hospitals to follow the Biomedical Waste Rules of 1998 for safe handling from point of generation to final disposal. Proper management is a legal and social responsibility to prevent disease transmission and environmental pollution.
The document discusses strategies for hospital waste management. It defines biomedical waste and outlines the key elements of the BMW Act and Rules, including classifications of waste, standards, and management steps. BMW is segregated into 4 categories and treated through various processes like incineration, autoclaving, or hydroclaving before disposal. Proper handling and treatment is important to reduce health and environmental risks from hazardous waste.
This document discusses bio-medical waste management. It defines different types of bio-medical waste and categories them based on risk level. It explains the potential health hazards posed by different types of waste and regulations for their proper treatment and disposal. The key methods of waste treatment discussed are incineration, autoclaving, chemical disinfection, and secured landfilling.
India is likely to generate about 775.5 tons of medical wast per day by 2020, from the current level of 550.9 tons per day growing at CAGR about 7%.
Safe and effective management of waste is not only a legal necessity but also a social responsibility.
The document discusses bio-medical waste management. It defines bio-medical waste and its categories. It notes that approximately 40 tons of waste is generated daily in India, but only 30% undergoes proper disposal. It outlines the various treatment and disposal methods for different categories of waste, including incineration, autoclaving, chemical treatment, and secured landfilling. Color coding and container requirements are also specified. The risks of exposure to healthcare waste include infections, genotoxicity, chemical toxicity, and radioactivity hazards. Proper waste management requires adherence to government rules and public education.
The document discusses biomedical waste management. It defines biomedical waste as waste generated during diagnosis, treatment, or immunization of humans or animals. It notes that biomedical waste includes infectious waste, pathological waste, sharps waste, pharmaceutical waste, genotoxic waste, chemical waste, and radioactive waste. The document also outlines the Ministry of Environment and Forest's classification of biomedical waste into 10 categories and the recommended treatment and disposal methods for each category. Key sources of biomedical waste are identified as hospitals, clinics, labs, and other healthcare facilities.
This document discusses bio medical waste management. It defines different types of hospital waste including biomedical waste. It classifies waste into hazardous and non-hazardous categories. Hazardous waste is further divided into infectious and toxic types. Ten categories of biomedical waste are outlined along with their color coding and appropriate treatment methods. The key steps in waste management are identified as survey, segregation, storage, transportation, treatment, and disposal. Common health risks of improper waste handling are also noted.
-Bio-Medical Waste
-Contents:
-Evolution of Bio-Medical Waste in India
-Biomedical Waste
-Need of Rules for Bio-Medical Waste
-Present Scenario in India
-Disease Caused by Improper Disposal of Waste
-BMW(H&M) 1998
-Major Differences between BMW 1998 and BMW 2016
-BMW (H&M) 2016
-Conclusion
Evolution of Bio-Medical Waste Management Rules in India:
-First Bio-Medical Rules were notified by the Govt. of India, erstwhile
MOEF on 20th July 1998.
-Modification in the next following years (2000, 2003 and 2011)
-BMW rules 2011 remained as the draft
-MOEFCC in March 2016 has amended the BMWM rules.
-BMW Management 2016 was released on 27 March 2016
Bio-Medical Waste:
means any waste, which is generated during the diagnosis, treatment or immunisation of human beings or animals
or research activities pertaining thereto
or in the production or testing of biological or in health camps, including the categories mentioned in Schedule I appended to these rules;
The document outlines guidelines for managing biomedical waste in hospitals. It discusses categorizing waste based on infectivity, proper segregation, collection, storage, and disposal methods. Training of staff, safety precautions, and regulatory compliance are important aspects of the waste management process. The goal is to minimize infectious waste production, safely dispose of waste, and prevent the spread of hospital-acquired infections.
This document provides information on the Bio Medical Waste Management Rules, 2016 in India. It introduces the rules and their objective of providing regulatory framework for managing bio-medical waste. It defines bio-medical waste and explains the types of waste generated from healthcare facilities. It emphasizes the importance of proper waste segregation and describes the 4 waste categories and their treatment and disposal requirements according to the rules. Improper management can pose health and environmental risks. The rules aim to standardize waste management practices across India.
This document discusses guidelines for biomedical waste management according to the BMW rules of 1998, 2011, and 2016 in India. It defines biomedical waste and outlines the objectives of proper waste management. It describes the classification of waste into categories based on risk level and provides guidelines for segregation, treatment, and disposal of each waste category according to the color-coding system. The risks of improper waste management to health and the environment are also discussed.
Bio Medical Waste Management And Handling Rules 1998ASHISH SINGH
The document discusses India's Bio-Medical Waste (Management and Handling) Rules 1998 which were established to regulate the management of biomedical waste from healthcare facilities. It defines biomedical waste and categories it based on potential hazards. The rules require all waste generators to treat and dispose of waste properly to prevent risks to public health and the environment. Facilities must segregate waste, maintain records, and report any accidents. The rules aim to formalize waste handling practices in India and prevent improper disposal of biomedical waste.
THIS presentation EXPLAINS biomedical waste management IN EASY WAY
Important links- NOTES- https://mynursingstudents.blogspot.com/
youtube channel
https://www.youtube.com/c/MYSTUDENTSU...
CHANEL PLAYLIST-
ANATOMY AND PHYSIOLOGY-https://www.youtube.com/playlist?list...
COMMUNITY HEALTH NURSING- https://www.youtube.com/playlist?list...
CHILD HEALTH NURSING- https://www.youtube.com/playlist?list...
FIRST AID- https://www.youtube.com/playlist?list...
HCM- https://www.youtube.com/playlist?list...
FUNDAMENTALS OF NURSING- https://www.youtube.com/playlist?list...
COMMUNICABLE DISEASES- https://www.youtube.com/playlist?list...
ENVIRONMENTAL HEALTH- https://www.youtube.com/playlist?list...
MSN- https://www.youtube.com/playlist?list...
HINDI ONLY- https://www.youtube.com/playlist?list...
ENGLISH ONLY- https://www.youtube.com/playlist?list...
facebook profile- https://www.facebook.com/suresh.kr.lrhs/
FACEBOOK PAGE- https://www.facebook.com/My-Student-S...
facebook group NURSING NOTES- https://www.facebook.com/groups/24139...
FOR MAKING EASY NOTES YOU CAN ALSO VISIT MY BLOG –
BLOGGER- https://mynursingstudents.blogspot.com/
Instagram- https://www.instagram.com/mystudentsu...
Twitter- https://twitter.com/student_system?s=08
#VITAMIN_A,#FUNCTIONS,#SOURCE, #DEFICIENCY,#DISEASE,#NIGHTBLINDNESS#XEROPHTHALMIA,#BITOTSPOT,#CORNEALXEROSIS, #CONJUNCIVALXEROSIS, YELLOWFRUITS,#MYSTUDENTSUPPORTSYSTEM, #rashes,#nursingclasses, #communityhealthnursing,#ANM, #GNM, #BSCNURING,#NURSINGSTUDENTS, #WHO,#NURSINGINSTITUTION,#COLLEGEOFNURSING,#nursingofficer,#COMMUNITYHEALTHOFFICER
This document provides information on biomedical waste management. It defines biomedical waste and discusses its various categories. It explains how biomedical waste is generated in healthcare facilities and needs to be properly segregated, stored, transported, and disposed of. The key steps in biomedical waste management are segregation according to waste type, proper labelling, collection from waste sources, short-term storage, transportation to treatment facilities, and final disposal. Worker safety is important, and personal protective equipment like gloves and protective clothing should be used when handling biomedical waste.
The document discusses biomedical waste management. It defines biomedical waste and notes that improper management poses health risks. The rules for management in India are outlined, including categories of waste and treatment methods like incineration and autoclaving. Proper procedures for storage, transportation, and disposal are important to implement the rules and prevent health and environmental issues.
This document discusses bio-medical waste (BMW), its sources, categories, and management. It notes that BMW has emerged as a global issue and safe, cost-effective management methods are needed. The major sources of BMW are hospitals, labs, research centers, and other healthcare facilities. BMW is categorized into 10 types including infectious waste, sharps, pharmaceutical waste, and more. The document outlines the risks of improper BMW handling and the legislation in place, the Bio-Medical Waste Management and Handling Rules, to ensure safe disposal. Color-coded segregation and treatment/disposal methods are prescribed for each waste category.
The document outlines the key aspects of the Bio-Medical Waste Management Rules 2016 in India. It defines bio-medical waste as any waste generated during diagnosis, treatment or immunization of humans or animals. It categorizes waste into 4 categories - yellow, red, white and blue and specifies waste types in each category. The rules mandate segregation of waste at source into appropriate color coded bins, appointment of waste management committees in large hospitals, and duties of waste generators and operators. It aims to ensure proper management of biomedical waste in India.
The document summarizes a study on bio-medical waste management practices at General Hospital in Sirsa, Haryana, India. The study found that while some practices like contracting a private agency for waste collection were in place, proper waste segregation and availability of designated bins were lacking. Recommendations included appointing staff to monitor waste management, conducting regular quality assessments, training and awareness programs for staff, and ensuring safety protocols and environmentally sound disposal practices are followed.
COVID19 PANDEMIC: ISSUES AND CHALLANGES IN BIOMEDICAL WASTE MANAGEMENTTanmayZoology
The document discusses biomedical waste (BMW), its sources, classification, management steps, and risks. It notes that BMW includes waste from healthcare facilities and comprises contaminated sharps, infectious, pathological and pharmaceutical waste. It classifies BMW as hazardous or non-hazardous. The key steps in BMW management are segregation, collection, storage, transportation, treatment and disposal. Common treatment methods include incineration, autoclaving, chemical disinfection. Untreated BMW poses infection and toxicity risks to waste handlers, the public and environment.
The document discusses bio-medical waste management issues and challenges faced by hospitals. It outlines various environmental laws related to waste management. It explains that healthcare waste includes waste generated in hospitals, laboratories, and research facilities. The basic principles of bio-medical waste management include segregation, containment, processing, storage and disposal of waste. Key challenges include lack of awareness, non-compliance with rules, inadequate protection of healthcare workers, and improper waste disposal. Addressing these issues requires robust policies, training, monitoring, and allocating sufficient resources.
Biomedical waste generation and management.pptJayRaval48
This document provides an overview of biomedical waste generation and management in India. It discusses that biomedical waste is generated from various medical facilities and includes human tissues, blood, chemicals, and other potentially infectious materials. The waste is categorized into 10 groups and proper management includes segregation, storage, transportation, and treatment. Common treatment methods include incineration, autoclaving, chemical disinfection, and irradiation which aim to safely dispose of waste and prevent health and environmental risks. Proper biomedical waste management is important for public health.
This document discusses biomedical waste management. It defines biomedical waste as waste generated during healthcare activities that requires safe handling due to potential pathogens. The waste is categorized as infectious, pathological, sharp, pharmaceutical, radioactive, and general. Proper management includes segregation, storage, transportation, and treatment of waste through incineration, autoclaving, or secured landfilling. Nurses play an important role in ensuring proper waste segregation and handling standards are followed within healthcare facilities. Failure to properly manage biomedical waste can spread infection and harm both healthcare workers and the environment.
The document defines biomedical waste and discusses its management according to Indian rules. It notes that biomedical waste includes waste generated from healthcare facilities like hospitals and can be infectious, pathological or hazardous. The rules categorize different types of biomedical waste and their treatment and disposal methods like incineration or autoclaving. The document also provides some statistics on biomedical waste generation rates in developed and developing countries.
The document discusses antimicrobial susceptibility testing (AST), which determines the susceptibility of bacteria to different antimicrobial agents through in-vitro laboratory procedures. It outlines various guidelines and standardization procedures for AST, including standardized bacterial inoculum, growth medium, incubation conditions, and antimicrobial concentrations. Common AST methods include dilution methods like broth microdilution and agar dilution, which determine minimum inhibitory concentrations (MICs), and diffusion methods like disc diffusion testing, which provide qualitative susceptibility results.
This document provides an overview of antigen processing and presentation. It discusses that antigen processing is needed to generate peptide fragments from proteins that can bind MHC molecules and be recognized by T cells. It describes the separate pathways for endogenous and exogenous antigen processing, which involve the cytosolic and endocytic pathways, respectively. The key steps in each pathway include protein degradation, peptide transport, and loading onto MHC class I or II molecules. The pathways ensure that intracellular and extracellular antigens are presented through distinct MHC complexes to CD8+ or CD4+ T cells to initiate appropriate immune responses.
This document discusses types of anaerobic bacteria and methods for culturing anaerobes. It describes three types of anaerobes: obligate anaerobes that cannot grow in oxygen, aerotolerant anaerobes that can tolerate limited oxygen, and microaerophilic bacteria that require oxygen. It also outlines several methods for culturing anaerobes, including producing a vacuum, oxygen displacement using hydrogen or carbon dioxide gas, oxygen absorption using copper or reducing agents, and using anaerobic chambers or glove boxes. Specimen collection and transport are also addressed.
Abnormal immunoglobulins and immunoglobulin specificities (1)Dr.Dinesh Jain
This document discusses various types of abnormal immunoglobulins and immunoglobulin specificities. It describes paraproteinemia, which is the presence of excessive amounts of a single monoclonal immunoglobulin. It discusses multiple myeloma, Bence Jones proteinuria, plasmacytoma, Waldenstrom's macroglobulinemia, monoclonal gammopathy of undetermined significance (MGUS), and the diagnostic criteria and characteristics of each.
Fungi that grow on crops can produce toxic substances called mycotoxins. Hundreds of mycotoxins have been identified from fungi such as Aspergillus, Fusarium, and Penicillium. Mycotoxins can contaminate foods and animal feeds, posing risks to human and animal health like cancer. Symptoms range from acute toxicity to long term effects. Regulatory limits aim to manage mycotoxin levels and prevent outbreaks.
Various types of microscopes and microscopy Dr.Dinesh Jain
This document provides an overview of various types of microscopes and microscopy techniques. It discusses phase contrast microscopy, which uses differences in phase of light waves passing through a specimen to provide contrast for viewing unstained live samples. Darkfield microscopy is described as using oblique illumination to view small particles against a dark background. Fluorescent microscopy involves staining specimens with fluorescent dyes and using ultraviolet light to view the fluorescent emissions. Finally, electron microscopes are able to achieve higher resolutions than light microscopes by using electron beams rather than visible light. Transmission electron microscopes transmit electrons through thin samples to form images.
This document discusses various systemic mycoses (fungal infections of internal organs) including histoplasmosis, blastomycosis, coccidioidomycosis, and paracoccidioidomycosis. It describes the causative fungi, how infection occurs through inhalation of spores, clinical features involving the respiratory system and dissemination, laboratory diagnosis using microscopy, culture, and immunodiagnosis, and treatment involving antifungal drugs. Candidiasis is also discussed as the most common fungal infection affecting mucosa and internal organs in immunocompromised individuals.
1. Superficial mycoses involve infections of the skin and its appendages by fungi including Malassezia species, dermatophytes, and others.
2. Common conditions include pityriasis versicolor caused by Malassezia furfur presenting as discolored patches, and tinea infections like tinea corporis caused by dermatophytes appearing as scaly rings.
3. Laboratory diagnosis involves potassium hydroxide microscopy of skin and nail samples to visualize fungal elements, and culture to isolate and identify the causative agent. Topical and oral antifungal drugs are used for treatment.
This document provides an overview of subcutaneous mycoses. It discusses several types including mycetoma, sporotrichosis, rhinosporidiosis, chromoblastomycosis, phaeohyphomycosis, and lobomycosis. For each condition, it summarizes the causative agent, clinical features, pathogenesis, diagnosis including direct examination and culture techniques, and treatment approaches. The document emphasizes that these infections usually follow trauma and develop subcutaneously at the site of inoculation, presenting with characteristic clinical features like tumefaction, draining sinuses, and presence of grains or granules.
Medical mycology is the study of fungi that impact human health. It has increased in importance with more immunosuppressed individuals. New diagnostic techniques allow for earlier detection of invasive fungal infections compared to traditional culture methods. Emerging fungal pathogens include non-albicans Candida species, Zygomycetes, and other molds in immunocompromised patients. Antifungal drug resistance is a growing problem, particularly in Candida species.
1. The document discusses various opportunistic mycoses including Candida, Aspergillus, and Zygomycetes.
2. It provides classifications of the organisms, compares true pathogenic fungi to opportunistic fungi, and describes various clinical manifestations including oral and disseminated candidiasis, allergic and systemic aspergillosis, and mucormycosis.
3. Laboratory diagnosis, culture characteristics, and treatment options are covered for each type of mycosis.
This document discusses the laboratory diagnosis of fungal infections through specimen collection, direct examination, culture, and other tests. It describes how to collect specimens from superficial, subcutaneous, and systemic fungal infections. Direct examination methods like KOH wet mounts, calcofluor white staining, and histopathology can provide early diagnosis. Fungal cultures are essential and involve using media like SDA, CMA, and BHI agar. Isolates are identified through morphology, biochemical profiling, and specialized techniques like CHROMagar. Serology detects antigens or antibodies. Skin tests and newer methods like PCR also aid diagnosis.
This document provides an introduction to mycology, the study of fungi. It discusses the history of fungi being recognized as pathogens and outlines the key characteristics of fungi such as cell walls containing chitin. Fungi can be classified based on cell morphology into yeasts, molds, and dimorphic fungi. They can also be classified based on sexual reproduction into four classes. Common fungal infections like dermatophytosis and opportunistic infections are described. The document concludes by noting some useful properties of fungi such as food production and antibiotic production.
This document discusses viral zoonotic diseases, with a focus on rabies. It defines zoonoses as diseases that can be transmitted between animals and humans. Rabies virus causes progressive infection of the central nervous system. Rabies occurs worldwide except Australia and Antarctica. Transmission is typically through bites from rabid animals, most commonly dogs. Symptoms in humans include pain at the bite site, hydrophobia, and paralysis. Laboratory diagnosis involves detecting the rabies virus or antibodies. Post-exposure prophylaxis includes wound cleansing, rabies immunoglobulin, and rabies vaccines. Prevention relies on surveillance, mass dog vaccination, population control, and public education.
This document defines various sterilization, disinfection, and asepsis terms and describes different sterilization methods. It discusses sterilization using heat, including pasteurization which reduces microorganisms rather than eliminating them completely. Physical sterilization methods like hot air ovens and chemical methods are also outlined. The document provides details on factors influencing the efficacy of sterilization and classifications of different sterilization techniques.
This document provides guidelines for collecting and transporting various clinical specimens for microbiological testing. Key points discussed include using properly labelled containers, collecting adequate sample volumes, avoiding contamination, and transporting specimens to the laboratory within 2 hours. Specimen collection procedures are described for various types of samples including blood, body fluids, cerebrospinal fluid, respiratory samples, and others. Transport involves using triple packaging and maintaining appropriate temperatures and conditions until the specimens can be processed in the laboratory.
Phase and antigenic variations in bacteriaDr.Dinesh Jain
This document discusses phase variation in bacteria. It begins by defining phase variation as a reversible switch in bacterial cells between expressing and not expressing proteins, which allows bacterial populations to adapt to changing environments without random mutations. It then describes 10 common phase variable phenotypes and molecular mechanisms of phase variation, including short sequence repeats, homologous recombination, and site-specific recombination. The document emphasizes that phase variation allows bacterial evasion of host immune responses by varying surface structures like capsules and proteins.
This document discusses various methods of chemical sterilization and disinfection. It defines key terms like sterilization, disinfection, antisepsis, and pasteurization. It describes different physical and chemical sterilizing agents such as heat, radiation, ethylene oxide, formaldehyde, and hydrogen peroxide. It classifies disinfectants based on their efficacy as high, intermediate, or low-level and outlines how items are classified based on Spaulding's system. Factors affecting disinfection effectiveness are also discussed.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Cell Therapy Expansion and Challenges in Autoimmune Disease
Bio medical waste managementt
1. Bio-Medical Waste Management
(Rules 2016)
DR. DINESH JAIN
DR. SANDEEP GUPTA
Government of india
Ministry of Enviornment, Forest and Climate change
New Delhi
2. “Bio-Medical waste” is the waste that is generated
during the diagnosis, treatment or immunization of
human beings or animals or research activities
pertaining thereto or in the production or testing of
biological or in health camps, including the categories
mentioned in Schedule I appended to BMW rules 2016”
“Any solid and/ liquid waste including its container and
any intermediate product, which is generated during the
diagnosis, treatment or immunization of human
beings or animals”. 2
3. CONTINUE
According to the environment protection act 1986, Biomedical
Waste (Management and Handling) Rules, 28 July 1998 And it
was amended in 2000 & 2003. the bio medical waste rules in July
1998, subsequently revised in 2011 & now the “bio medical waste
management rules in 2016” are in the attestation to the commitment
of the Gov. of India. (bio medical waste
Management Amendment 2018)
Waste in India - 484 tonnes/day of bmw from 1,68,869 health care
centres
Average 1-2kg/bed/day.
3
4. WHO’S AT RISK
11
Doctor’s & Nurses
Patients
Hospital support staff
support staff Waste collection &
disposal staff
General public and the
Environment
5. NEED FOR BMW MANAGEMENT
TYPE OFWASTE Health HAZARD
Human/ Anatomical waste/ soiled waste HIV, HBV, Cholera, T.B, Pneumonia Rabies
e.t.c.
Sharps HIV, HBV, HCV, Injuries
Cytotoxic/ radioactive Cancer, Birth defect
Chemical waste Poisning, dermatitis, conjuctivitis
4
The hospital waste, in addition to the risk for
patient & personal who handle these
waste poses a threat to public health &
enviroment.
7. PRESENT SENERIO
Acc. To the M.O.E.F. & CC (Ministry of
Environment, Forest & climate change )-
Gross generation of BMW in india is 484
tone/ day from 1,68,869 health care
facilities (hcf), out of which 447 tone/ day
is treated, which means that almost 38 tone/
day of the wastes is left untreated & not
disposed finding its way in dumps or water
bodies & re-enters our system. 6
8. BIO-MEDICAL WASTE MANAGEMENT & HANDLING
RULES NOTIFICATIONS AND AMENDMENTS
On 20th July 1998 Ministry of Environment and Forests
(MoEF), Govt. of India, Framed a rule known as ‘Bio-
medical Waste (Management and Handling) Rules,
1st Amendment Dated 06/03/2000
2nd Amendment Dated 17/09/2003
The MoEF&CC has notified the new BMW (M) Rules, 2016
on 28TH March, under the Environment (Protection) Act,
1986 to replace the earlier Rules (1998) and the
7
amendments thereof.
9. If you are not measuring
it, you are not
managing it.
9
13. WHO ESTIMATES
1
3
85% of hospital waste is non hazardous
10% is infectious
5% is non-infectious
Any infectious or non infectious Bio hazardous waste mixed
with general waste renders the whole bio hazardous waste .
15. BIO HAZARDOUS WASTE
Infectious waste – 10% (sharp, non sharp, plastics, disposables,
liquid
waste)
Non infectious waste – 5% (radioactive waste, discarded
glass, chemical waste, incinerated waste)
WHO has estimated that 16 billion injection are administered
every
year. Not all needles & syringes are disposed properly.
Despite this progress, In the year 2010, unsafe injection were
still responsible for as many as 33,800 new HIV infections,
1.7 million hepatitis B infections & 3,15,000 hepatitis C
infections.
Any infectious or non infectious Bio hazardous waste mixed
with general waste renders the whole bio hazardous waste .
10
16. SOURCES OF BIO-MEDICAL
WASTE
16
Major Sources Minor Sources
Clinics (Dental &
Ayu.) Cosmetic
clinics
Home care
Paramedics
Funeral
services
All Hospitals
Labs
Research centers
Animal research
Blood banks
Nursing homes
Mortuaries
Autopsy centers
17. HOSPITAL WASTEDISPOSAL
17
Basic principal is that the wastes are disposed in most
hygienic & cost effective manner, by methods which at
all stages, minimize risk to healthy environment, Govt. of
India has prescribed certain procedures and guidelines as
follows:
Source Segregation
Collection of wastes
Storage
Transport
Treatment
Disposal
18. BIO MEDICAL WASTE MANAGEMENT RULES
Schedule – 6 18
Acc. To BMW Rules of 1998 The duty of every “occupier”
i.e. A person who has the control over the institution or its
premises, to take all steps to ensure that waste generated is
handled without any adverse effect to human health &
environment. It consists of six schedule-
Schedule – 1
Schedule – 2
Schedule – 3
Schedule – 4
Schedule – 5
19. Color Coding & Type Of Container/Bags to
Be Used For Waste Segregation &
Collection
21. Category Type of Waste Type of Bag or
Container to be used
Yellow (a) Human Anatomical Waste:
Human tissues, organs, body parts and fetus below the viability period
Yellow coloured non-
chlorinated plastic bags
(b)Animal Anatomical Waste :
Experimental animal carcasses, body parts, organs, tissues, including
the waste generated from animals used in experiments or testing in
veterinary hospitals or colleges or animal houses.
(c) Soiled Waste:
Items contaminated with blood, body fluids like dressings, plaster
casts cotton swabs and bags containing residual or discarded blood and
blood components.
(d) Expired or Discarded Medicines:
Pharmaceutical waste like antibiotics, cytotoxic drugs including all
items contaminated with cytotoxic drugs along with glass or plastic
ampoules, vials etc.
Yellow coloured non-
chlorinated plastic bags
or containers
(e) Chemical Waste:
Chemicals used in production of biological and used or discarded
disinfectants.
Yellow coloured
containers or non-
chlorinated plastic bags
22. (f) Chemical Liquid Waste :
Liquid waste generated due to use of chemicals in
production of
biological and used or discarded disinfectants,
Silver X-ray film
developing liquid, discarded Formalin, infected
secretions, aspirated body fluids, liquid from
laboratories and floor washings, cleaning, house-
keeping and disinfecting activities etc.
Separate collection system
leading to effluent treatment
system
(g) Discarded linen, mattresses, beddings
contaminated with blood or body fluid.
Non-chlorinated yellow plastic
bags or suitable packing
material
(h) Microbiology, Biotechnology and other
clinical laboratory waste:
Blood bags, Laboratory cultures, stocks or
specimens of microorganisms, live or attenuated
vaccines, human and animal cell cultures used in
research, industrial laboratories, production
of biological, residual toxins, dishes and devices
used for cultures.
Autoclave safe plastic bags or
containers
23. Red Contaminated Waste (Recyclable)
(a) Wastes generated from disposable items
such as tubing, bottles, intravenous tubes and
sets, catheters, urine bags, syringes
(withoutneedles and fixed needle syringes) and
vaccutainers with their needles cut) and gloves.
Red coloured non-
chlorinated plastic bags or
containers
White
(Transluc
ent)
Waste sharps including Metals:
Needles, syringes with fixed needles, needles
from needle tip cutter or burner, scalpels,
blades, or any other contaminated sharp object
that may cause puncture and cuts. This
includes both used,discarded and contaminated
metal sharps
Puncture proof, Leak proof,
tamper proof containers
Blue (a) Glassware:
Broken or discarded and contaminated glass
including medicine vials and ampoules except
those contaminated with cytotoxic wastes.
Cardboard boxes with blue
colored marking
(b) Metallic Body Implants Cardboard boxes with blue
colored marking
24. SCHEDULE – 1 NEW 8 CATEGORIES OF BMW IN 1998
CATE TYPE OF WASTE
GORY
PANCHA-
KARMA
WASTE
TREATMENT &
DISPOSAL
Catego
ry 1
Human anatomical wastes Vomitus Incineration/ deep burial
Catego
ry 2
Animal wastes Incineration/ deep burial
Catego
ry 3
Microbiology & biotechnology
waste, Liquid wastes,
waste from Laboratory,
blood banks, hospitals,
house etc.
Blood Local autoclaving/
microwaving/
incineration/
Disinfection by
chemicals
Catego
ry 4
Waste sharps like needles,
syringes, scalpels, blades,
glass etc.
Needle Disinfection
(Chemical/autoclavin
15
g/
micro waving &
mutilation/shredding)
25. CATEG
ORY
TYPE OF WASTE PANCHA-
KARMA
WASTE
TREATMENT &
DISPOSAL
Catego
ry 5
Discarded Medicines &
cytotoxic drugs
Incineration/
destruction & disposal
in land fills
Catego
ry 6
Soiled wastes
Items contaminated with
blood, body fluids including
cotton, dressings etc
Cotton,
Dressing
material
Incineration,
autoclaving,
microwaving
Catego
ry 7
Solid wastes like catheters,
IV sets etc
Catheter Disinfection by chemical
treatment/autoclaving/
micro waving and
mutilation & shredding
Catego
ry 8
Liquid Waste Disinfecting by
chemical T/t and
discharge into dra
1
in
6
s
26. CATEGORY TYPE OF WASTE PANCHA-KARMA
WASTE
TREATMENT &
DISPOSAL
Category 9 IncinerationAsh Disposal in
municipal landfill
Category 10 Chemical wastes Oil Chemical
treatment &
discharge into
drains for liquid
and secured land
fills for solids.
17
27. Colour Coding Type of container to
be used
Waste Category
Number
Treatment
Yellow plastic bags Category 1,2,3,6
Red Disinfected container
/ plastic bags
Category 3,6,7
Incineration,
Deep burial
Autoclaving,
Microwaving,
Chemical T/t
Blue /
white
plastic bags/
puncture proof
container
Category 4&7 Autoclaving,
Microwaving,
Chemical T/t &
Black plastic bags Category 5,9,10
Shredding
18
Disposal in
secured landfill
37. SCHEDULE- 3
LABEL FOR BIO-MEDICALWASTE
CONTAINERS/BAGS (PART- A)
27
BIO HAZRDS
SYMBOL
CYTOTOXIC
SYMBOL
BIO HAZARDS WASTE
WITH CARE
NOTE - LABLE SHALL BE NON WASHABLE&
PROMINANTELY VISIBLE
38. Day ............ Month .............. Year ...........
Date of generation ...................
Waste category ........
Waste class Waste description
Sender's Name & Address
Phone No...........Telex No .... Fax No .................
Receiver's Name & Address
Phone No ……..Telex No ...........Fax No ...............
Contact Person ........ In case of emergency
38
41. PRECAUTIONS
41
Medical, Paramedical & Sanitation staff should be vaccinated against
Hepatitis B
Using especially heavy duty gloves,Aprons, Masks, Boots while
dealing with infectious wastes
Recapping needles should be discouraged. In case, if unavoidable
single handed method should be used
Segregation of Biomedical Waste & Safe disposal.
42. 33
BAD- Don’t carry waste in open bag’s &
never carry it through crowded area
GOOD- Always carry the wastein
secure sealed container/ bags
48. TRANSPORTATION
Untreated bio medical waste should be transported in
specially designed vehicles
Trolley or in covered wheel barrows.
Manual loading should be avoided as far as possible.
The bags /container containing biomedical waste should
be tied /lidded before transportation.
Before transportation, signed document by doctor /nurse
maintaining date, shift, quantity & destination.
Special vehicle must be used to prevent access direct
contact with the transportation operators, the scavengers
& the public. 34
49. The transport containers should be properly enclosed.
Driver must be trained regarding the procedures
followed during the accidental spillage.
Wash the interior of the containers thoroughly.
Biohazard symbol should be painted on the trolley.
35
52. WASTE TREATMENT PROCESS
CATEGORIES
Five broad categories:
(1) Mechanical processes
(2) Thermal processes
(3) Chemical processes
(4) Irradiation processes
(5) Biological processes.
52
53. MECHANICAL PROCESSES
53
Used to change the physical form or
characteristics of the waste
To facilitate waste handling or to process the
waste in conjunction with other treatment steps.
Includes- compaction
- shredding
- land fill and burial
54. CONTINUE
Compaction- compressing the waste into containers to
reduce its volume.
Shredding – includes granulation, grinding, pulping &
the like, is used to break the waste into smaller pieces.
Health & safety reasons and good practice prohibit
compacting/shredding untreated medical waste, because
of concerns of aerosoling /spilling of micro-organisms.
However, there are no ill effects if waste is sheredded
after it has been decontaminated in order to make it
unrecognisable. 39
55. SANITARY & SECURED LAND FILLING
55
Deep burial of human anatomical waste, when the
facility of proper incineration is not available.
Disposal of autoclaved /hydroclaved /microwaved
waste.
Disposal of sharps.
Disposal of incineration ash.
56. PIT FOR DEEP BURRIAL
56
Depth 2 meter
Waste fill 1 meter from bottom
Cover of lime- 50 cm
Galvanized iron/ wire mesh at the top
Secure the area
57. THERMAL PROCESSES
57
Sterilize or destroyes medical waste.
Two categories-low heat systems & high heat systems
Low heat systems-use steam, hot water or
electromagnetic radiation to heat & decontaminate the
waste.
High heat systems-combustion, pyrolysis & high temp.
plasmas to decontaminate & destroy the waste.
58. CONT.
58
Hot air oven:
Temp. OF 160 degree for 2 hour or 170 degree for 1 hour, for
glass ware, & metallic instruments.
Incineration:
Destruction of contaminated materials in the incinerator.
Autoclave
steam sterilisation under pressure by bringing the
Steam into direct contact with the waste material to sterilize it.
59. CHEMICAL PROCESSES
59
Most chemical waste treatment systems use a
disinfectant solution in combination with shredding to
provide decontamination & disfigurement.
1% hypochlorite solution with a minimum contact
period of 30 min.
Pre-shredding of the waste is desirable for better contact
with the waste material.
60. IRRADIATION PROCESS
60
Ionizing- Xray, gamma ray, cosmic rays.
Non ionizing- infra red, ultra violet.
Swabs, plastic materials, oil, metal foils, etc.
These system requires post-irradiation shredding to
render the waste unrecognisable.
61. AUTOCLAVE
Principle:
When water is heated in a closed vessel under
pressure, the boiling point of water rises above 100
degree.
Water is heated at 2 atmospheric pressure and the
boiling temperature will be 121 degree or at 3
atmospheric pressure and the boiling temperature
will be 134 degree.
61
62. AUTOCLAVING IS HIGLY EFFICIENT BCOZ
High temperature.
High penetrating power of the steam under
pressure.
When steam condenses on the articles, it liberates
latent heat to the articles to be sterilized.
Non toxic
Not time consuming.
62
63. INCINERATION
63
Incineration fundamentals:
-incineration comes from a greek word meaning
burn to ashes.
-initially incinerators were just uncontrolled single
chamber fire boxes provided with smoke stocks.
-now modern incineration systems are well
engineered, well designed, well controlled, well
monitored
64. CONT.
64
Incineration is a high temperature thermal process
employing combustion of the waste under controlled
condition for converting them into inert material &
gases.
This can be oil fired/electrically powered/
combination.
65. MICROWAVE TREATMENT
65
Radiations produced by the microwave are
involved to break apart molecular chemical bonds
& thus disinfect infectious waste.
Temp-97◦-100◦C
Cycle time-40-45 min.
Advantage of disinfecting the waste
No hazardous emissions.
Can not be used to treat body parts & tissues.
66. ADVANTAGES :
However, the investment costs are high atpresent.
66
Absence of harmful air emissions- environment
friendly.
Absence of liquid discharges.
Non-requirement of chemicals.
Reduced volume of waste (due to shredding &
moisture loss)
Operator safety-worker friendly
68. CONCLUSION
53
It is just not the law abide compliance but the
Social RESPONSIBILITY of every Health Care
Establishment to say…
NO TO HAZARD OF BIOMEDICAL WASTE
It will only take..
Proper planning.
Spread Awareness.
Involvement everyone.
Segregation, Pre-treatment at first stage.
Appropriate Storage
Timely Disposal.
All Records…
And………………………….. ALLCLEAN.
69. LET THE WASTE OF THE “SICK” NOT
CONTAMINATE THE LIVES OF
“THE HEALTHY”
70. 54
LET THE WASTE OF THE “SICK”NOT
CONTAMINATE THE LIVES OF
“THE HEALTHY”